SCHEMBL3075337

SCHEMBL3075337

c1ccc2nc3nc[nH]c3cc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
HPGD P15428 3/20 0.53
KDM4E B2RXH2 3/20 0.53
GLA P06280 2/20 0.53
GAA P10253 2/20 0.53
HSD17B10 Q99714 1/20 0.53
MAPT P10636 2/20 0.46
ACHE P22303 1/20 0.46
PDE2A O00408 1/20 0.43
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
CDK2 P24941 1/20 0.42
KMT2A Q03164 1/20 0.42
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ADORA3 P0DMS8 2/20 0.41
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acridine SCHEMBL9437430 0.77 ALDH1A1 (0.58) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL30492958 0.76 BRD4 (0.44) ALDH1A1KDM4ECDK2ADORA2AADORA1
SCHEMBL1233156 0.76 BRD4 (0.44) ALDH1A1KDM4ECDK2ADORA2AADORA1
SCHEMBL11547422 0.75 SRC (0.56) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL22717057 0.75 KDM4E (0.36) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL10637092 0.75 PDE3B (0.46) ALDH1A1HPGDKDM4EGLAGAA
Acridine SCHEMBL3851265 0.75 ALDH1A1 (0.46) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL5721357 0.74 ALDH1A1 (0.49) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL17265808 0.74 ALDH1A1 (0.52) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL4132133 0.74 KDM4E (0.52) ALDH1A1HPGDKDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119798327-A Novel quinoline imidazole skeleton chiral nitrogen phosphine ligand compound and synthetic method and application thereof 浙江师范大学 2025-04-11 CN claimed
CN-114805354-A Preparation method of quinoline-2-thioketone compound 河南工程学院 2022-07-29 CN claimed
EP-0541153-A1 1,3-Dihydro-2H-imidazo[4,5-b]-quinolin-2-one derivatives as phosphodiesterase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1993-05-12 EP claimed
US-5153104-A Negative-acting photothermographic imaging systems comprising also a nitrate, an initiator, a leuco dye and a binder; colorfastness; clean background MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1992-10-06 US claimed
US-20260090195-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2026-03-26 US disclosed
CN-121270554-B Quinoline imidazole derivative and preparation method and application thereof 北京大学第一医院(北京大学第一临床医学院) 2026-03-13 CN disclosed
CN-121270554-A Quinoline imidazole derivative and preparation method and application thereof 北京大学第一医院(北京大学第一临床医学院) 2026-01-06 CN disclosed
CN-119798327-A Novel quinoline imidazole skeleton chiral nitrogen phosphine ligand compound and synthetic method and application thereof 浙江师范大学 2025-04-11 CN disclosed
CN-112778300-B Organic compound and organic electroluminescent device containing the same 北京鼎材科技有限公司 2024-02-02 CN disclosed
WO-2023168908-A1 FUSED QUINONE OXIME IMIDAZOLE, ONIUM DERIVATIVE THEREOF, PREPARATION THEREFOR AND USE THEREOF 上海交通大学 2023-09-14 WO disclosed
CN-114805354-A Preparation method of quinoline-2-thioketone compound 河南工程学院 2022-07-29 CN disclosed
CN-107207434-B Organic molecules, in particular for use in optoelectronic devices 西诺拉股份有限公司 2021-11-23 CN disclosed
EP-1599473-A1 IMIDAZO 4,5-B QUINOLINE-DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS ALTANA Pharma AG (DE) 2005-11-30 EP disclosed
WO-2004076451-A1 IMIDAZO[4,5-B]QUINOLINE-DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS ALTANA PHARMA AG (DE) 2004-09-10 WO disclosed
EP-0541153-A1 1,3-Dihydro-2H-imidazo[4,5-b]-quinolin-2-one derivatives as phosphodiesterase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1993-05-12 EP disclosed
EP-0541153-A1 1,3-Dihydro-2H-imidazo[4,5-b]-quinolin-2-one derivatives as phosphodiesterase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1993-05-12 EP disclosed
US-4965179-A Silver halide color photographic material FUJI PHOTO FILM CO., LTD. (JP) 1990-10-23 US disclosed
US-4713316-A INFRARED SENSITIZING DYES, MOBILE DYE PRECURSORS, ALKALI, SILVER HALIDE EMULSION FUJI PHOTO FILM CO., LTD. (JP) 1987-12-15 US disclosed
EP-0086230-B1 MEROCYANINE-CYANINE-MEROCYANINE (MCM) ELECTRICALLY PHOTOSENSITIVE COLORANTS EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1987-01-07 EP disclosed
US-4463076-A Merocyanine-cyanine-merocyanine (MCM) electrically photosensitive colorants for photoelectrophoretic imaging EASTMAN KODAK COMPANY (US) 1984-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260090195-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LBR, GLRA1, GLRB ALDH1A1 2803/4885HPGD 3302/4885KDM4E 3308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.